美国 · 平台与数据 · MarketWatch
The FDA declined to approve one of biotech’s most closely watched cancer drugs
详细摘要
The regulator told Summit Therapeutics that the lung-cancer drug needs to prove it can help people live longer.
MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.marketwatch.com)




